Main > ONCOLOGY (**) > Gastric Cancer>MET or R PD-L1+*** > Treatment > USA. M. PembrolizuMAb>> > Companion Diagnostics>

---

Companion Diagnostics>'s subsections
>(*) USA Approval Date: 2017. 09.22
>Company
>Patent>Assignee; Claims; No.; Etc.
>Patent>UpDate: 2019. 12.31.
>PR Web-Site
>TradeMark

Companion Diagnostics>'s products
This section has no products